Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 625

B8ta’s series C retails for $50m

Macy’s has returned for a $50m series C round for B8ta, which is gearing up to add a fashion and lifestyle offering to its retail services.

Nov 4, 2019

Geltor to apply for $100m

Geltor, backed by Archer Daniels Midland and Wilbur-Ellis, is seeking between $50m and $100m in a series B round to scale its collagen manufacturing capabilities.

Nov 4, 2019

Smartworks figures out $25m series A

Keppel Land has provided $25m in series A financing to Smartworks as the co-working spaces provider plans to strengthen its position in existing markets and enter new locations.

Nov 4, 2019

DotData process $23m series A

DotData has brought its total equity financing to $43m after adding $23m in series A funding to its coffers thanks to investors including NEC.

Nov 4, 2019

Sensely tees up fresh capital

Sensely has collected funding from a consortium led by insurance firm Aflac to haul its lifetime total to $26.5m.

Nov 4, 2019

Sensely tees up fresh capital

Stanford-StartX Fund portfolio company Sensely collected funding from a consortium led by insurance firm Aflac to haul its lifetime total to $26.5m.

Nov 4, 2019

PierianDx clinches $27m series B

Genomics bioinformatics platform developer PierianDx has raised capital from investors including Inova Health Systems and RTI International to advance its business strategy.

Nov 4, 2019

Corporate venturing deal net: 28 October-1 November 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Nov 1, 2019

Tmunity teams with corporates to raise $75m

University of Pennsylvania returned for a series B round that boosted its immunotherapy spinout's overall funding to $231m.

Nov 1, 2019

Tmunity teams with corporates to raise $75m

Gilead Sciences and Be The Match BioTherapies returned for a series B round that boosted the immunotherapy developer's overall funding to $231m.

Nov 1, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here